🔗 Permalink

Inventor profile of:

John A. Bender

City:

Middletown, Connecticut

Country:

United States

Published Applications:

Last publication date:

2016-11-24

Top Assignees for applications by John A. Bender

The entities that hold a legal rights for patent applications filed by inventor Bender John A.:

BRISTOL-MYERS SQUIBB COMPANY 36 Princeton, NJ United States
ViiV Healthcare UK (No.5) Limited 1 Brentford, Middlesex, United Kingdom
ViiV HealthCare UK (No. 5) Limited 1 Brentford, Middlesex, United Kingdom

Recent patent applications by Bender John A.

John A. Bender from Middletown, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-11-24

US20160338999A1

Human necessities

Hepatitis C virus inhibitors

#2 | 2016-10-27

US20160311806A1

Chemistry; metallurgy

4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV INHIBITORS

#3 | 2016-09-08

US20160257645A1

Chemistry; metallurgy

Inhibitors of human immunodeficiency virus replication

#4 | 2016-02-25

US20160052924A1

Chemistry; metallurgy

2-keto amide derivatives as HIV attachment inhibitors

#5 | 2015-11-12

US20150322048A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#6 | 2015-09-10

US20150252028A1

Chemistry; metallurgy

HEPATITIS C VIRUS INHIBITORS

#7 | 2015-07-16

US20150197499A1

Chemistry; metallurgy

Hepatitis C Virus Inhibitors

#8 | 2014-07-24

US20140205564A1

Chemistry; metallurgy

Hepatitis C Virus Inhibitors

#9 | 2014-07-03

US20140186299A1

Chemistry; metallurgy

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

#10 | 2014-02-13

US20140045816A1

Chemistry; metallurgy

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

#11 | 2014-01-16

US20140018389A1

Chemistry; metallurgy

Hepatitis C Virus Inhibitors

#12 | 2014-01-09

US20140012020A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#13 | 2013-08-01

US20130197012A1

Human necessities

Compounds for the treatment of hepatitis C

#14 | 2013-07-04

US20130171098A1

Human necessities

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

#15 | 2013-05-16

US20130121957A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#16 | 2013-05-09

US20130115193A1

Chemistry; metallurgy

Hepatitis C Virus Inhibitors

#17 | 2013-01-31

US20130028859A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#18 | 2013-01-10

US20130012540A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#19 | 2012-12-13

US20120316126A1

Human necessities

Compounds for the Treatment of Hepatitis C

#20 | 2012-09-13

US20120232099A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#21 | 2012-08-09

US20120201783A1

Human necessities

Compounds for the treatment of hepatitis C

#22 | 2012-08-02

US20120195857A1

Chemistry; metallurgy

Hepatitis C Virus Inhibitors

#23 | 2012-05-10

US20120115847A1

Chemistry; metallurgy

Compounds for the Treatment of Hepatitis C

#24 | 2011-12-22

US20110311480A1

Chemistry; metallurgy

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

#25 | 2011-11-24

US20110286961A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#26 | 2011-11-17

US20110281910A1

Chemistry; metallurgy

Hepatitis C Virus Inhibitors

#27 | 2011-11-10

US20110274648A1

Chemistry; metallurgy

Hepatitis C Virus Inhibitors

#28 | 2011-10-20

US20110256099A1

Human necessities

Compounds for the treatment of hepatitis C

#29 | 2011-04-28

US20110098327A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#30 | 2011-03-31

US20110077280A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#31 | 2011-01-27

US20110020277A1

Chemistry; metallurgy

Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors

#32 | 2011-01-27

US20110020276A1

Chemistry; metallurgy

Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors

#33 | 2011-01-20

US20110014154A1

Chemistry; metallurgy

Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors

#34 | 2010-09-30

US20100249094A1

Human necessities

Compounds for the treatment of hepatitis C

#35 | 2010-08-26

US20100216774A1

Chemistry; metallurgy

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

#36 | 2010-08-26

US20100215616A1

Chemistry; metallurgy

Hepatitis C virus inhibitors

#37 | 2010-07-22

US20100184800A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#38 | 2010-04-15

US20100093694A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#39 | 2010-03-11

US20100063068A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#40 | 2009-06-25

US20090162318A1

Chemistry; metallurgy

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

#41 | 2009-05-21

US20090130057A1

Chemistry; metallurgy

Compounds for the treatment of Hepatitis C

#42 | 2009-05-21

US20090130056A1

Chemistry; metallurgy

Compounds for the treatment of Hepatitis C

#43 | 2008-09-18

US20080227769A1

Chemistry; metallurgy

Compounds for the treatment of Hepatitis C

#44 | 2008-09-18

US20080226592A1

Chemistry; metallurgy

Compounds for the treatment of Hepatitis C

#45 | 2008-09-18

US20080226591A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#46 | 2008-09-18

US20080226590A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#47 | 2008-07-17

US20080171015A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#48 | 2008-06-19

US20080146537A1

Chemistry; metallurgy

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

#49 | 2008-05-29

US20080125439A1

Chemistry; metallurgy

Diazaindole-dicarbonyl-piperazinyl antiviral agents

#50 | 2007-11-22

US20070270406A1

Chemistry; metallurgy

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

#51 | 2007-11-22

US20070270405A1

Chemistry; metallurgy

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

#52 | 2007-08-09

US20070184024A1

Chemistry; metallurgy

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

#53 | 2007-04-05

US20070078122A1

Chemistry; metallurgy

Indolobenzazepine HCV NS5B inhibitors

#54 | 2007-03-15

US20070060565A1

Chemistry; metallurgy

Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors

#55 | 2005-06-09

US20050124623A1

Chemistry; metallurgy

Diazaindole-dicarbonyl-piperazinyl antiviral agents

InventorID:

30078 ⎘